Abstract
The P450 family of proteins has more than 1000 representatives,which despite sometimes relatively low sequence identity have a surprisingly high level of structural similarity.This fact makes this family of proteins ideal candidate for various types of modeling based on protein structure prediction.A number of P450 proteins,including CYPs 1A1,1A2,1B1,3A4,11B2,17,and 19,play a role in the metabolism of estrogen.Inhibitors of these proteins could be very promising drugs for hormonal treatment of postmenopausal breast cancer.Population studies have yielded a significant amount of data describing the relationship between single nucleotide polymorphisms (SNP)in DNA and cancer risk related to these proteins. A combination of SNP analysis with protein structure prediction can be a very useful strategy in investigations of structure-functional relations of P450 proteins and structure-based drug design.Here we will demonstrate how protein structure prediction combined with genetic SNP analysis can be useful for potential drug design and possibly,individual treatment of breast cancer.
Keywords: P450, breast cancer, proteins, postmenopausal
Current Medicinal Chemistry
Title: SNP Analysis Combined with Protein Structure Prediction Defines Structure- Functional Relationships in Cancer Related Cytochrome P450 Estrogen Metabolism
Volume: 11 Issue: 5
Author(s): Igor F. Tsigelny, Vladimir Kotlovyi and Linda Wasserman
Affiliation:
Keywords: P450, breast cancer, proteins, postmenopausal
Abstract: The P450 family of proteins has more than 1000 representatives,which despite sometimes relatively low sequence identity have a surprisingly high level of structural similarity.This fact makes this family of proteins ideal candidate for various types of modeling based on protein structure prediction.A number of P450 proteins,including CYPs 1A1,1A2,1B1,3A4,11B2,17,and 19,play a role in the metabolism of estrogen.Inhibitors of these proteins could be very promising drugs for hormonal treatment of postmenopausal breast cancer.Population studies have yielded a significant amount of data describing the relationship between single nucleotide polymorphisms (SNP)in DNA and cancer risk related to these proteins. A combination of SNP analysis with protein structure prediction can be a very useful strategy in investigations of structure-functional relations of P450 proteins and structure-based drug design.Here we will demonstrate how protein structure prediction combined with genetic SNP analysis can be useful for potential drug design and possibly,individual treatment of breast cancer.
Export Options
About this article
Cite this article as:
Tsigelny F. Igor, Kotlovyi Vladimir and Wasserman Linda, SNP Analysis Combined with Protein Structure Prediction Defines Structure- Functional Relationships in Cancer Related Cytochrome P450 Estrogen Metabolism, Current Medicinal Chemistry 2004; 11 (5) . https://dx.doi.org/10.2174/0929867043455882
DOI https://dx.doi.org/10.2174/0929867043455882 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Metastasis-Initiating Cells in Renal Cancer
Current Signal Transduction Therapy Recent Evidence on the Role of Dietary PUFAs in Cancer Development and Prevention
Current Medicinal Chemistry Design and Development of Signal Transduction Inhibitors for Cancer Treatment: Experience and Challenges with Kinase Targets
Current Signal Transduction Therapy Cancer-Targeting Multifunctionalized Gold Nanoparticles in Imaging and Therapy
Current Medicinal Chemistry Recent Advances in Colon Drug Delivery Technology
Drug Delivery Letters Development of a Radiolabeled Amlodipine Analog for L-type Calcium Channel Imaging
Current Radiopharmaceuticals Radionuclide Liver Cancer Therapies: From Concept to Current Clinical Status
Anti-Cancer Agents in Medicinal Chemistry Development of New Drugs that Act Through Membrane Receptors and Involve an Action of Inverse Agonism
Recent Patents on CNS Drug Discovery (Discontinued) Mammalian DNA (Cytosine-5) Methyltransferase Mechanisms and RNA-Mediated Inhibition for Future Therapies
Epigenetic Diagnosis & Therapy (Discontinued) Recent Developments on 1,2,4-Triazole Nucleus in Anticancer Compounds: A Review
Anti-Cancer Agents in Medicinal Chemistry CAM Use in Pediatric Oncology
Current Pediatric Reviews Modulation of Immuno-biome during Radio-sensitization of Tumors by Glycolytic Inhibitors
Current Medicinal Chemistry The JNK Signaling Pathway Is a Novel Molecular Target for S-Propargyl- L-Cysteine, a Naturally-Occurring Garlic Derivatives: Link to Its Anticancer Activity in Pancreatic Cancer In Vitro and In Vivo
Current Cancer Drug Targets Apoptosis Imaging to Monitor Cancer Therapy: The Road to Fast Treatment Evaluation?
Current Pharmaceutical Biotechnology Gold Nanoparticles; Potential Nanotheranostic Agent in Breast Cancer: A Comprehensive Review with Systematic Search Strategy
Current Drug Metabolism Low Molecular Weight and Oligomeric Chitosans and Their Bioactivities
Current Topics in Medicinal Chemistry HER2-targeted Therapeutic Strategies for HER2-positive Metastatic Breast Cancers
Current Cancer Therapy Reviews Mechanisms of Drug Resistance to Vascular Endothelial Growth Factor (VEGF) Inhibitors
Anti-Cancer Agents in Medicinal Chemistry Overexpression of Nemo-like Kinase Promotes the Proliferation and Invasion of Lung Cancer Cells and Indicates Poor Prognosis
Current Cancer Drug Targets The Journey From Metabolic Profiling to Biomarkers: The Potential of NMR Spectroscopy Based Metabolomics in Neurodegenerative Disease Research
Current Metabolomics